Nucleic Acid-based Therapeutics Market to Reach USD 14.25 Billion by 2031 Driven by Surge in...

Published on 19 Apr 2024 on Digital Journal

The demand for nucleic acid-based therapeutics has soared in recent years due to their effectiveness...

Read the rest of the article

Start tracking your investments with Statfolio

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) just released its latest first-quarter results and th...

Simply Wall St. via Yahoo Finance 6 May 2024

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam ...

Insider Monkey via Yahoo Finance 4 May 2024

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) showcases robust revenue growth with a 54.8% increase i...

GuruFocus.com via Yahoo Finance 3 May 2024

Free Report) reported first-quarter 2024 adjusted loss of 16 cents per share, narrower than the...

Zacks 3 May 2024

The demand for nucleic acid-based therapeutics has soared in recent years due to their effectiven...

Digital Journal 19 Apr 2024

One stock that might be an intriguing choice for investors right now is Alnylam Pharmaceuticals, ...

Zacks via Yahoo Finance 8 Apr 2024

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standar...

Investing.com 7 Apr 2024

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript February 15, 2024 Al...

Insider Monkey via Yahoo Finance 16 Feb 2024

Alnylam Pharmaceuticals Inc. saw its stock price sink to its lowest point in the last year after ...

The Business Journals 16 Feb 2024

Alnylam Pharmaceuticals ALNY reported a loss of $1.10 per share in the fourth quarter of 2023, na...

Zacks via Yahoo Finance 16 Feb 2024